Phillip Parente – Projects — Monash University

View Scopus Profile

EmailPhillip.Parentemonashedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

9 Finished

9 results

Filter

Finished

BMS-734016 - CA184104: Randomised, Multicentre, Double-blind, Phase 3 Trial comparing the efficacy of Ipilimumab in addition to Paclitaxel and Carboplatin versus placebo in addition
Parente, P.
1/11/14 → 31/12/15
Project: Research
A Phase 2 randomised double blind study comparing tremelimumab to placebo in second or third treatment of subjects with unresectable pleural or peritonela malignant mesothelioma
Parente, P.
1/08/13 → 31/08/14
Project: Research
A phase 3, randomised double blind study of Nivolumab Monaotherapy or Nivolumab combined with Ipilimumab versus Ipilimumab monotherapy in subjects with previously untreated unresectable or metastatic
Parente, P.
20/06/13 → 15/10/14
Project: Research
Phase 3 randomized double-blind controlled trial of Cabozantinib (XL 184) vs Mitoxantrone plus Prednisone in men with previously treated symptomatic castration-resistant prostate cance (XL 184-306)
Parente, P.
1/05/13 → 30/11/13
Project: Research
A phase III randomised double blind placebo controlled study of Vemurafenib (ro5185426) adjuvant therapy in patients with surgically resected, cutaneous braf mutant melanoma at high risk of recurrenc
Parente, P.
1/03/13 → 31/05/14
Project: Research
Phase 3 randomised double blind study of dabrafenib (GSK2118436) in combination with trametinib (GSK1120212) versus placebo in adjuvant treatment of high-risk BRAF V600
Parente, P.
15/12/12 → 16/08/14
Project: Research
Study comparing Cabazitaxel/Prednisone in combination with Custirsen (OGX-011) to Cabazitaxel/Prednisone for second-line chemotherapy in men with metastatic castrate resistant prostate cancer
Parente, P.
1/10/12 → 30/06/14
Project: Research
A phase 3 randomised open-labeled study comparing the combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib to the BRAF inhibitor vemurafenib in subjects with unresectable or m
Parente, P.
1/09/12 → 1/06/13
Project: Research
Oncology Clinical Trials
Parente, P.
1/01/05 → 31/12/20
Project: Research